Baltimore City Secures $80 Million Opioid Settlement with Teva Pharmaceuticals
Monday, 9 September 2024, 07:32
Baltimore City Wins $80 Million from Teva Pharmaceuticals
BALTIMORE -- The City of Baltimore has reached an $80 million settlement with Teva Pharmaceuticals over the company’s role in the city’s opioid crisis, officials announced Monday.
Settlement Breakdown
Teva will pay an initial $35 million by the end of the year, with the remainder due by July 1, 2025. This marks the fourth settlement in Baltimore’s ongoing litigation against opioid distributors and manufacturers.
- Previous agreements include:
- $45 million from Allergan
- $45 million from CVS
- $152.5 million from Cardinal Health
The total recoveries from opioid defendants now stand at $322.5 million.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.